Bilimsel Makale Arama | NeuralCipher AI

Açık erişim

LRRK2 mutations in Parkinson's disease: confirmation of a gender effect in the Italian population.

Cilia R, Siri C, Rusconi D, Allegra R, Ghiglietti A, Sacilotto G, Zini M, Zecchinelli AL, Asselta R, Duga S, Paganoni AM, Pezzoli G, Seia M, Goldwurm S.

Parkinsonism Relat Disord · 2014-04-25

DOI: 10.1016/j.parkreldis.2014.04.016PMID: 24816003

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

The screening of the 3'UTR sequence of LRRK2 identified an association between the rs66737902 polymorphism and Parkinson's disease.

Cardo LF, Coto E, Ribacoba R, Mata IF, Moris G, Menéndez M, Alvarez V.

J Hum Genet · 2014-04-24

DOI: 10.1038/jhg.2014.26PMID: 24758914

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

The Parkinson disease-linked LRRK2 protein mutation I2020T stabilizes an active state conformation leading to increased kinase activity.

Ray S, Bender S, Kang S, Lin R, Glicksman MA, Liu M.

J Biol Chem · 2014-04-02

DOI: 10.1074/jbc.m113.537811PMID: 24695735

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Ribosomal protein s15 phosphorylation mediates LRRK2 neurodegeneration in Parkinson's disease.

Martin I, Kim JW, Lee BD, Kang HC, Xu JC, Jia H, Stankowski J, Kim MS, Zhong J, Kumar M, Andrabi SA, Xiong Y, Dickson DW, Wszolek ZK, Pandey A, Dawson TM, Dawson VL.

Cell · 2014-04-01

DOI: 10.1016/j.cell.2014.01.064PMID: 24725412

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Açık erişim

LRRK2 and neuroinflammation: partners in crime in Parkinson's disease?

Russo I, Bubacco L, Greggio E.

J Neuroinflammation · 2014-03-21

DOI: 10.1186/1742-2094-11-52PMID: 24655756

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Identification of blood serum micro-RNAs associated with idiopathic and LRRK2 Parkinson's disease.

Botta-Orfila T, Morató X, Compta Y, Lozano JJ, Falgàs N, Valldeoriola F, Pont-Sunyer C, Vilas D, Mengual L, Fernández M, Molinuevo JL, Antonell A, Martí MJ, Fernández-Santiago R, Ezquerra M.

J Neurosci Res · 2014-03-20

DOI: 10.1002/jnr.23377PMID: 24648008

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Does uncoupling protein 2 expression qualify as marker of disease status in LRRK2-associated Parkinson's disease?

Grünewald A, Arns B, Meier B, Brockmann K, Tadic V, Klein C.

Antioxid Redox Signal · 2014-03-07

DOI: 10.1089/ars.2013.5737PMID: 24251413

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Parkinson disease-associated mutation R1441H in LRRK2 prolongs the "active state" of its GTPase domain.

Liao J, Wu CX, Burlak C, Zhang S, Sahm H, Wang M, Zhang ZY, Vogel KW, Federici M, Riddle SM, Nichols RJ, Liu D, Cookson MR, Stone TA, Hoang QQ.

Proc Natl Acad Sci U S A · 2014-03-03

DOI: 10.1073/pnas.1323285111PMID: 24591621

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Prediction of the repeat domain structures and impact of parkinsonism-associated variations on structure and function of all functional domains of leucine-rich repeat kinase 2 (LRRK2).

Mills RD, Mulhern TD, Liu F, Culvenor JG, Cheng HC.

Hum Mutat · 2014-02-24

DOI: 10.1002/humu.22515PMID: 24470158

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

[Pathogenesis of Parkinson's disease through LRRK2 mutation].

Ohta E, Obata F.

Seikagaku · 2014-02-01

PMID: 24693706

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

A voxel-based morphometry and diffusion tensor imaging analysis of asymptomatic Parkinson's disease-related G2019S LRRK2 mutation carriers.

Thaler A, Artzi M, Mirelman A, Jacob Y, Helmich RC, van Nuenen BF, Gurevich T, Orr-Urtreger A, Marder K, Bressman S, Bloem BR, Hendler T, Giladi N, Ben Bashat D, LRRK2 Ashkenazi Jewish Consortium.

Mov Disord · 2014-01-30

DOI: 10.1002/mds.25827PMID: 24482120

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

MAPT IVS1+124 C>G modifies risk of LRRK2 G2385R for Parkinson's disease in Chinese individuals.

Dan X, Wang C, Ma J, Feng X, Wang T, Zheng Z, Chan P.

Neurobiol Aging · 2014-01-25

DOI: 10.1016/j.neurobiolaging.2014.01.025PMID: 24559644

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kayıtlar bilimsel kaynaklardan alınır. Bibliyografik kayıt sayısı, Türkçe çeviri veya editoryal onay sayısı değildir.

785 makale bulundu

LRRK2 mutations in Parkinson's disease: confirmation of a gender effect in the Italian population.

The screening of the 3'UTR sequence of LRRK2 identified an association between the rs66737902 polymorphism and Parkinson's disease.

The Parkinson disease-linked LRRK2 protein mutation I2020T stabilizes an active state conformation leading to increased kinase activity.

Ribosomal protein s15 phosphorylation mediates LRRK2 neurodegeneration in Parkinson's disease.

LRRK2 and neuroinflammation: partners in crime in Parkinson's disease?

Identification of blood serum micro-RNAs associated with idiopathic and LRRK2 Parkinson's disease.

Does uncoupling protein 2 expression qualify as marker of disease status in LRRK2-associated Parkinson's disease?

Parkinson disease-associated mutation R1441H in LRRK2 prolongs the "active state" of its GTPase domain.

Prediction of the repeat domain structures and impact of parkinsonism-associated variations on structure and function of all functional domains of leucine-rich repeat kinase 2 (LRRK2).

[Pathogenesis of Parkinson's disease through LRRK2 mutation].

A voxel-based morphometry and diffusion tensor imaging analysis of asymptomatic Parkinson's disease-related G2019S LRRK2 mutation carriers.

MAPT IVS1+124 C>G modifies risk of LRRK2 G2385R for Parkinson's disease in Chinese individuals.

Filtreler